Literature DB >> 6411388

In vivo metabolism of human apoprotein A-I-phospholipid complexes. Comparison with human high density lipoprotein-apoprotein A-I metabolism.

C L Malmendier, C Delcroix, J P Ameryckx.   

Abstract

The metabolism of apolipoprotein A-I was investigated in healthy young adults. The apoprotein was injected intravenously in one of the four following forms: radiolabelled high density lipoproteins, HDL incubated with labelled apo A-I, labelled A-I-dipalmitoyl- or dimyristoylphosphatidylcholine complexes or free apoprotein A-I. The radioactivity-time curves of high density lipoproteins were followed for 15 days. The kinetic studies demonstrate similar fractional catabolic rates, half-lifes and rates of synthesis. Fractional catabolic rate calculated from plasma data was in reasonable agreement with the value derived from the urine/plasma activity ratio. When free apo A-I was injected, the unusual form of the U/P ratio curve is interpreted as the result of different fates of the injected molecules. This study indicates that the half-life of apo A-I seems not to be affected by the form in which the apoprotein is injected and that kinetics of apo A-I-phospholipid complexes may be used as a valid index of apoprotein A-I/HDL metabolism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6411388     DOI: 10.1016/0009-8981(83)90089-x

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  9 in total

1.  A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates.

Authors:  E A Brinton; S Eisenberg; J L Breslow
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

2.  The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase.

Authors:  E Nobecourt; M J Davies; B E Brown; L K Curtiss; D J Bonnet; F Charlton; A S Januszewski; A J Jenkins; P J Barter; K-A Rye
Journal:  Diabetologia       Date:  2007-01-10       Impact factor: 10.122

3.  Exchange of apolipoprotein A-I between lipid-associated and lipid-free states: a potential target for oxidative generation of dysfunctional high density lipoproteins.

Authors:  Giorgio Cavigiolio; Ethan G Geier; Baohai Shao; Jay W Heinecke; Michael N Oda
Journal:  J Biol Chem       Date:  2010-04-12       Impact factor: 5.157

4.  Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys.

Authors:  I J Goldberg; W S Blaner; T M Vanni; M Moukides; R Ramakrishnan
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

Review 5.  Engineered nanoparticles mimicking cell membranes for toxin neutralization.

Authors:  Ronnie H Fang; Brian T Luk; Che-Ming J Hu; Liangfang Zhang
Journal:  Adv Drug Deliv Rev       Date:  2015-04-11       Impact factor: 15.470

6.  Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women.

Authors:  E A Brinton; S Eisenberg; J L Breslow
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

7.  Evaluation of apolipoprotein A-I kinetics in rabbits in vivo using in situ and exogenous radioiodination methods.

Authors:  Bo Zhang; Eiso Shimoji; Hiroaki Tanaka; Keijiro Saku
Journal:  Lipids       Date:  2003-03       Impact factor: 1.880

8.  Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia.

Authors:  E A Brinton; S Eisenberg; J L Breslow
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

9.  Recombinant high-density lipoprotein nanoparticles containing gadolinium-labeled cholesterol for morphologic and functional magnetic resonance imaging of the liver.

Authors:  Mengjie Rui; Wei Guo; Qian Ding; Xiaohui Wei; Jianrong Xu; Yuhong Xu
Journal:  Int J Nanomedicine       Date:  2012-07-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.